Evidence map›Paper›PMID 39745710›Full record

ArticleJAMA oncology2025

Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Nonrandomized Clinical Trial.

Bradford S Hoppe, Sarah A Milgrom, Lindsay A Renfro, Yue Wu, Cindy L Schwartz, Louis S Constine, Kathleen M McCarten, Kara M Kelly, David Hodgson, Sharon M Castellino and 1 more

Abstract readComment
In one paragraph

Article in JAMA oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Bradford S HoppeDepartment of Radiation Oncology, Mayo Clinic, Jacksonville, Florida.
Sarah A MilgromDepartment of Radiation Oncology, University of Colorado, Aurora.
Lindsay A RenfroDivision of Biostatistics, University of Southern California, Los Angeles.
Yue WuChildren's Oncology Group, Monrovia, California.
Cindy L SchwartzDivision of Pediatric Hematology, Oncology, BMT, Medical College of Wisconsin, Milwaukee.
Louis S ConstineDepartments of Radiation Oncology and Pediatrics, University of Rochester, Rochester, New York.
Kathleen M McCartenImaging and Radiation Oncology Core, Lincoln, Rhode Island.
Kara M KellyDepartment of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York.
David HodgsonRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Sharon M CastellinoDepartment of Pediatric Oncology, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia.
Frank G KellerDepartment of Pediatric Oncology, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia.

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
Advancing novel therapeutics and translational science to close the survivorship gap in pediatric, adolescent and young adult (AYA) lymphomaR50CA285492 · NCI · EMORY UNIVERSITY · PI SHARON MARIE CASTELLINO · 2024 to 2026
$537k
NCI NIH HHS R50 CA285492NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39745710
PMCPMC11837869

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.